| Product Code: ETC13145184 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Gestational Diabetes Market was valued at USD 2.8 Billion in 2024 and is expected to reach USD 4 Billion by 2031, growing at a compound annual growth rate of 5.20% during the forecast period (2025-2031).
The global gestational diabetes market is witnessing growth due to the increasing prevalence of gestational diabetes, which is a common pregnancy-related complication resulting in high blood sugar levels. Factors such as sedentary lifestyles, unhealthy dietary habits, and rising maternal age contribute to the rising incidence of gestational diabetes worldwide. Diagnostic tests, monitoring devices, and treatment options such as medication and insulin therapy are key components of the market. The market is also driven by advancements in technology, such as the development of continuous glucose monitoring systems, to better manage gestational diabetes. With a focus on early detection and effective management of gestational diabetes to prevent adverse outcomes for both the mother and baby, the global market for gestational diabetes is expected to continue growing.
The Global Gestational Diabetes Market is witnessing a growing emphasis on early diagnosis and management of the condition, leading to increased demand for glucose monitoring devices and diagnostic tests. The market is also being driven by the rising prevalence of gestational diabetes worldwide, particularly in developing countries. Opportunities exist for innovative technologies such as continuous glucose monitoring systems and smartphone apps for self-management. Additionally, collaborations between healthcare providers, pharmaceutical companies, and research institutions are fostering advancements in treatment options and personalized care for pregnant women with gestational diabetes. Overall, the market is poised for growth as awareness about the risks associated with gestational diabetes increases and healthcare systems prioritize preventive measures and improved patient outcomes.
The Global Gestational Diabetes Market faces several challenges including limited awareness among pregnant women about the condition, leading to underdiagnosis and inadequate management. Additionally, the lack of standardization in screening protocols and diagnostic criteria across different regions hinders effective detection and treatment. Furthermore, the stigma associated with gestational diabetes can discourage women from seeking proper medical care. Access to affordable and comprehensive healthcare services, especially in developing countries, is another significant challenge, impacting the overall management of gestational diabetes. Moreover, the increasing prevalence of risk factors such as obesity and unhealthy lifestyles further complicates the management of gestational diabetes, emphasizing the need for more targeted interventions and awareness campaigns to address these challenges.
The global gestational diabetes market is primarily driven by the increasing prevalence of gestational diabetes among pregnant women worldwide. Factors such as sedentary lifestyles, unhealthy dietary habits, and rising obesity rates contribute to the growing incidence of gestational diabetes. Additionally, advancements in healthcare infrastructure, improved diagnostic techniques, and rising awareness about maternal health are also driving market growth. Furthermore, the increasing focus on early detection and management of gestational diabetes to prevent adverse pregnancy outcomes and long-term health complications for both mother and child is propelling the demand for innovative treatment options and therapeutic interventions in the global gestational diabetes market.
Government policies related to the Global Gestational Diabetes Market primarily focus on promoting early detection, management, and prevention strategies to reduce the impact of gestational diabetes on maternal and fetal health. These policies often include guidelines for screening pregnant women, providing access to healthcare services and education on gestational diabetes, implementing nutrition and lifestyle interventions, and ensuring appropriate medical management during pregnancy. Additionally, governments may support research initiatives to improve understanding of gestational diabetes and develop innovative solutions for its prevention and treatment. Overall, these policies aim to enhance maternal and child health outcomes, reduce healthcare costs associated with gestational diabetes, and promote public awareness and education on this important health issue.
The Global Gestational Diabetes Market is expected to experience significant growth in the coming years due to factors such as the increasing prevalence of gestational diabetes worldwide, growing awareness about the condition, and advancements in diagnostic technologies and treatment options. The market is likely to be driven by the rising incidence of obesity and sedentary lifestyles, which are key risk factors for gestational diabetes. Additionally, the focus on early detection and management of gestational diabetes to prevent long-term health complications for both mothers and babies is expected to fuel market growth. With a growing emphasis on maternal health and well-being, the Global Gestational Diabetes Market is poised for expansion, with opportunities for innovative solutions and personalized care approaches to meet the evolving needs of patients and healthcare providers.
In the global gestational diabetes market, Asia Pacific is expected to witness significant growth due to the rising prevalence of gestational diabetes in countries like India and China. North America is projected to hold a prominent share, driven by advanced healthcare infrastructure and increasing awareness about gestational diabetes. Europe is also a key market, with a growing focus on early diagnosis and management of gestational diabetes. In the Middle East and Africa region, the market is likely to expand due to improving healthcare facilities and rising investments in women`s health. Latin America is anticipated to experience moderate growth, supported by initiatives to enhance maternal healthcare services and increasing healthcare expenditure in countries like Brazil and Mexico. The global gestational diabetes market is characterized by a mix of regional dynamics, reflecting varying levels of healthcare infrastructure and awareness across different regions.
Global Gestational Diabetes Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Gestational Diabetes Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Gestational Diabetes Market Revenues & Volume, 2021 & 2031F |
3.3 Global Gestational Diabetes Market - Industry Life Cycle |
3.4 Global Gestational Diabetes Market - Porter's Five Forces |
3.5 Global Gestational Diabetes Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Gestational Diabetes Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Global Gestational Diabetes Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Global Gestational Diabetes Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Global Gestational Diabetes Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Global Gestational Diabetes Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Gestational Diabetes Market Trends |
6 Global Gestational Diabetes Market, 2021 - 2031 |
6.1 Global Gestational Diabetes Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Gestational Diabetes Market, Revenues & Volume, By Insulin, 2021 - 2031 |
6.1.3 Global Gestational Diabetes Market, Revenues & Volume, By SGLT-2 inhibitor, 2021 - 2031 |
6.1.4 Global Gestational Diabetes Market, Revenues & Volume, By Alpha-glucosidase inhibitor, 2021 - 2031 |
6.1.5 Global Gestational Diabetes Market, Revenues & Volume, By Other, 2021 - 2031 |
6.2 Global Gestational Diabetes Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Gestational Diabetes Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.2.3 Global Gestational Diabetes Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.2.4 Global Gestational Diabetes Market, Revenues & Volume, By Other, 2021 - 2031 |
6.3 Global Gestational Diabetes Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Gestational Diabetes Market, Revenues & Volume, By Online Channel, 2021 - 2031 |
6.3.3 Global Gestational Diabetes Market, Revenues & Volume, By Offline Channel, 2021 - 2031 |
6.4 Global Gestational Diabetes Market, Revenues & Volume, By End-User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Gestational Diabetes Market, Revenues & Volume, By Hospital Pharmacies, 2021 - 2031 |
6.4.3 Global Gestational Diabetes Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.4.4 Global Gestational Diabetes Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
7 North America Gestational Diabetes Market, Overview & Analysis |
7.1 North America Gestational Diabetes Market Revenues & Volume, 2021 - 2031 |
7.2 North America Gestational Diabetes Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Gestational Diabetes Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.4 North America Gestational Diabetes Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5 North America Gestational Diabetes Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6 North America Gestational Diabetes Market, Revenues & Volume, By End-User, 2021 - 2031 |
8 Latin America (LATAM) Gestational Diabetes Market, Overview & Analysis |
8.1 Latin America (LATAM) Gestational Diabetes Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Gestational Diabetes Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Gestational Diabetes Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.4 Latin America (LATAM) Gestational Diabetes Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.5 Latin America (LATAM) Gestational Diabetes Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8.6 Latin America (LATAM) Gestational Diabetes Market, Revenues & Volume, By End-User, 2021 - 2031 |
9 Asia Gestational Diabetes Market, Overview & Analysis |
9.1 Asia Gestational Diabetes Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Gestational Diabetes Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Gestational Diabetes Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.4 Asia Gestational Diabetes Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.5 Asia Gestational Diabetes Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9.6 Asia Gestational Diabetes Market, Revenues & Volume, By End-User, 2021 - 2031 |
10 Africa Gestational Diabetes Market, Overview & Analysis |
10.1 Africa Gestational Diabetes Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Gestational Diabetes Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Gestational Diabetes Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.4 Africa Gestational Diabetes Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.5 Africa Gestational Diabetes Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10.6 Africa Gestational Diabetes Market, Revenues & Volume, By End-User, 2021 - 2031 |
11 Europe Gestational Diabetes Market, Overview & Analysis |
11.1 Europe Gestational Diabetes Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Gestational Diabetes Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Gestational Diabetes Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.4 Europe Gestational Diabetes Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.5 Europe Gestational Diabetes Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11.6 Europe Gestational Diabetes Market, Revenues & Volume, By End-User, 2021 - 2031 |
12 Middle East Gestational Diabetes Market, Overview & Analysis |
12.1 Middle East Gestational Diabetes Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Gestational Diabetes Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Gestational Diabetes Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Gestational Diabetes Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.4 Middle East Gestational Diabetes Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.5 Middle East Gestational Diabetes Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12.6 Middle East Gestational Diabetes Market, Revenues & Volume, By End-User, 2021 - 2031 |
13 Global Gestational Diabetes Market Key Performance Indicators |
14 Global Gestational Diabetes Market - Export/Import By Countries Assessment |
15 Global Gestational Diabetes Market - Opportunity Assessment |
15.1 Global Gestational Diabetes Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Gestational Diabetes Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.3 Global Gestational Diabetes Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.4 Global Gestational Diabetes Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
15.5 Global Gestational Diabetes Market Opportunity Assessment, By End-User, 2021 & 2031F |
16 Global Gestational Diabetes Market - Competitive Landscape |
16.1 Global Gestational Diabetes Market Revenue Share, By Companies, 2024 |
16.2 Global Gestational Diabetes Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |